Prelude Capital Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
51,267
-36
-0.1% -$213 0.03% 676
2026
Q1
$211K Buy
51,303
+12,000
+31% +$58.1K 0.02% 889
2025
Q4
$261K Buy
39,303
+4,036
+11% +$27.3K 0.02% 866
2025
Q3
$217K Buy
+35,267
New +$275K 0.02% 903
2023
Q3
Sell
-16,122
Closed -$117K 1192
2023
Q2
$117K Buy
+16,122
New +$139K 0.01% 912
2020
Q3
Sell
-200
Closed -$1K 1961
2020
Q2
$1K Hold
200
﹤0.01% 1865
2020
Q1
$1K Buy
+200
New +$1.7K ﹤0.01% 1339

Other funds holding EOLS

Prelude Capital Management's EOLS Position: Q2 2026 in Review

Prelude Capital Management reduced its Evolus (EOLS) stake by 0.07% in Q2 2026, selling an estimated $213 and leaving 51,267 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #676.

Prelude Capital Management first reported a position in EOLS in Q1 2020 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Prelude Capital Management held 51,267 shares of Evolus worth $356K as of Q2 2026.
  • Prelude Capital Management sold 36 Evolus shares in Q2 2026, an estimated $213.
  • Evolus made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #676 holding.
  • Prelude Capital Management first reported a position in Evolus in Q1 2020 and has held it in 7 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.